Safety and effectiveness of dipeptidyl peptidase-4 inhibitors versus intermediate-acting insulin or placebo for patients with type 2 diabetes failing two oral antihyperglycaemic agents: a systematic review and network meta-analysis (Q34767965)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Safety and effectiveness of dipeptidyl peptidase-4 inhibitors versus intermediate-acting insulin or placebo for patients with type 2 diabetes failing two oral antihyperglycaemic agents: a systematic review and network meta-analysis	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

4 August 2017

1 reference

8 February 2023

1 reference

systematic review

1 reference

comparative study

1 reference

Safety and effectiveness of dipeptidyl peptidase-4 inhibitors versus intermediate-acting insulin or placebo for patients with type 2 diabetes failing two oral antihyperglycaemic agents: a systematic review and network meta-analysis (English)

1 reference

Europe PubMed Central

4 August 2017

1 reference

based on heuristic

inferred from abstract

type 2 diabetes

1 reference

4 February 2021

dipeptidyl peptidase-4 inhibitors

1 reference

30 January 2021

glycated hemoglobin

1 reference

1 February 2021

1 reference

anti-diabetic medication

1 reference

12

1 reference

Europe PubMed Central

4 August 2017

Sharon E Straus

14

object named as

Sharon E Straus

0 references

object named as

Brian Hutton

10

0 references

object named as

Paul A Khan

3

0 references

Andrea C. Tricco

1

object named as

Andrea C Tricco

1 reference

Europe PubMed Central

4 August 2017

Brenda R. Hemmelgarn

11

object named as

Brenda R Hemmelgarn

1 reference

Europe PubMed Central

4 August 2017

Charlene Soobiah

8

object named as

Charlene Soobiah

1 reference

Europe PubMed Central

4 August 2017

7

object named as

Erik Blondal

1 reference

Europe PubMed Central

4 August 2017

6

object named as

Huda Ashoor

1 reference

Europe PubMed Central

4 August 2017

2

object named as

Jesmin Antony

1 reference

Europe PubMed Central

4 August 2017

4

object named as

Marco Ghassemi

1 reference

Europe PubMed Central

4 August 2017

5

object named as

Jemila S Hamid

1 reference

Europe PubMed Central

4 August 2017

Sumit Ranjan Majumdar

13

object named as

Sumit R Majumdar

1 reference

Europe PubMed Central

4 August 2017

author name string

Catherine H Yu

9

1 reference

Europe PubMed Central

4 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

23 December 2014

14 references

Europe PubMed Central

4 August 2017

13 March 2019

14 March 2019

24 March 2019

2 October 2019

17 November 2019

18 November 2019

20 November 2019

27 November 2019

14 December 2019

30 January 2021

1 February 2021

4 February 2021

8 February 2023

11 references

Europe PubMed Central

4 August 2017

2 October 2019

17 November 2019

18 November 2019

20 November 2019

27 November 2019

14 December 2019

30 January 2021

1 February 2021

4 February 2021

8 February 2023

4

1 reference

Europe PubMed Central

4 August 2017

e005752

1 reference

Europe PubMed Central

4 August 2017

12

1 reference

Europe PubMed Central

4 August 2017

copyright license

Creative Commons Attribution-NonCommercial

13 references

13 March 2019

14 March 2019

24 March 2019

2 October 2019

17 November 2019

18 November 2019

20 November 2019

27 November 2019

14 December 2019

30 January 2021

1 February 2021

4 February 2021

8 February 2023

on focus list of Wikimedia project

0 references

Alogliptin after acute coronary syndrome in patients with type 2 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4275675

7 July 2018

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4275675

7 July 2018

Safety, effectiveness, and cost of dipeptidyl peptidase-4 inhibitors versus intermediate acting insulin for type 2 diabetes: protocol for a systematic review and network meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4275675

7 July 2018

Choice of therapy in patients with type 2 diabetes inadequately controlled with metformin and a sulphonylurea: a systematic review and mixed-treatment comparison meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4275675

7 July 2018

Sitagliptin exerts an antinflammatory action

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4275675

7 July 2018

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4275675

7 July 2018

Effect of antihyperglycemic agents added to metformin and a sulfonylurea on glycemic control and weight gain in type 2 diabetes: a network meta-analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4275675

7 July 2018

Assessing the sensitivity of meta-analysis to selection bias: a multiple imputation approach.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4275675

7 July 2018

Checking consistency in mixed treatment comparison meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4275675

7 July 2018

An evidence-based practice guideline for the peer review of electronic search strategies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4275675

7 July 2018

A case study of multiple-treatments meta-analysis demonstrates that covariates should be considered

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4275675

7 July 2018

Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4275675

7 July 2018

Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4275675

7 July 2018

Combination of direct and indirect evidence in mixed treatment comparisons

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4275675

7 July 2018

Quantifying heterogeneity in a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4275675

7 July 2018

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4275675

7 July 2018

Bias in meta-analysis detected by a simple, graphical test

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4275675

7 July 2018

Meta-analysis in clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4275675

7 July 2018

Glycemic control continues to deteriorate after sulfonylureas are added to metformin among patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2014-005752

21 January 2018

Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2014-005752

21 January 2018

Inference from Iterative Simulation Using Multiple Sequences

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2014-005752

21 January 2018

Efficacy and safety of sitagliptin added to ongoing metformin and pioglitazone combination therapy in a randomized, placebo-controlled, 26-week trial in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2014-005752

21 January 2018

A randomized non-inferiority study comparing the addition of exenatide twice daily to sitagliptin or switching from sitagliptin to exenatide twice daily in patients with type 2 diabetes experiencing inadequate glycaemic control on metformin and sita

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2014-005752

21 January 2018

Efficacy and safety of linagliptin in persons with type 2 diabetes inadequately controlled by a combination of metformin and sulphonylurea: a 24-week randomized study.

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2014-005752

21 January 2018

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin.

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2014-005752

21 January 2018

Systematic Reviews and Meta-Analysis

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2014-005752

21 January 2018

Identifiers

10.1136/BMJOPEN-2014-005752

1 reference

Europe PubMed Central

4 August 2017

1 reference

Europe PubMed Central

4 August 2017

1 reference

Europe PubMed Central

4 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34767965&oldid=1971240610"